In an unexpected twist, Novartis has gotten caught up in the messy investigation into Michael Cohen, President Trump’s personal attorney.

The drug maker confirmed it entered into a previously undisclosed agreement last year with Essential Consultants, which is reportedly a shell company that Cohen used to make payments for various matters.